Piscataqua Savings Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5K Hold
55
0.01% 325
2026
Q1
$9.49K Hold
55
0.01% 342
2025
Q4
$11K Hold
55
0.01% 321
2025
Q3
$8.61K Hold
55
0.01% 297
2025
Q2
$8.35K Hold
55
0.01% 296
2025
Q1
$8.28K Hold
55
0.01% 277
2024
Q4
$10.2K Hold
55
0.01% 270
2024
Q3
$10.8K Hold
55
0.01% 266
2024
Q2
$11.4K Hold
55
0.01% 259
2024
Q1
$14.9K Hold
55
0.01% 245
2023
Q4
$13K Hold
55
0.01% 250
2023
Q3
$10.8K Hold
55
0.01% 265
2023
Q2
$11.6K Hold
55
0.01% 261
2023
Q1
$11.1K Buy
+55
New +$12.5K 0.01% 266

Other funds holding CRL

Piscataqua Savings Bank's CRL Position: Q2 2026 in Review

Piscataqua Savings Bank held its Charles River Laboratories (CRL) position steady in Q2 2026 at 55 shares worth $12.5K. The position accounts for 0.01% of the portfolio, ranked #325.

Piscataqua Savings Bank first reported a position in CRL in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.9K in Q1 2024. 93 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Piscataqua Savings Bank held 55 shares of Charles River Laboratories worth $12.5K as of Q2 2026.
  • Piscataqua Savings Bank left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 0.01% of Piscataqua Savings Bank's portfolio in Q2 2026, its #325 holding.
  • Piscataqua Savings Bank first reported a position in Charles River Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Piscataqua Savings Bank's Charles River Laboratories position peaked at $14.9K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.